AZ, Daiichi get FDA nod for Dato-DXd in breast cancer | pharmaphorum

Retrieved on: 2025-01-19 02:36:53

Tags for this article:

Click the tags to see associated articles and topics

AZ, Daiichi get FDA nod for Dato-DXd in breast cancer | pharmaphorum. View article details on hiswai:

Excerpt

AstraZeneca and Daiichi Sankyo have claimed FDA approval for a second antibody-drug conjugate for breast cancer, TROP2-directed Datroway.

Article found on: pharmaphorum.com